about
Protein- and diabetes-induced glomerular hyperfiltration: role of glucagon, vasopressin, and ureaCerebral oedema during treatment of diabetic ketoacidosis: are we any nearer finding a cause?Low water intake and risk for new-onset hyperglycemia.Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient Brattleboro rats.Agents in development for the treatment of diabetic nephropathy.Plasma Copeptin, AVP Gene Variants, and Incidence of Type 2 Diabetes in a Cohort From the Community.Plasma copeptin and the risk of diabetes mellitus.Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31).Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome.Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria.Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies.Vasopressin and metabolic disorders: translation from experimental models to clinical use.Elevated copeptin is associated with atherosclerosis and diabetic kidney disease in adults with type 1 diabetes.Silkworm (Bombyx mori L.) reduces vasopressin expression in the hypothalamus of streptozotocin-induced diabetic mice.Attenuation of vasopressin-induced antidiuresis in poorly controlled type 2 diabetes.Hydration and kidney health.A case of insulin edema with inappropriate hyperaldosteronism.Acute and chronic hyperglycemic effects of vasopressin in normal rats: involvement of V1A receptors.Osmolal effects on vasopressin secretion in the streptozotocin-diabetic rat.Osmoregulation of thirst and vasopressin secretion in human subjects: effect of various solutes.Albuminuria is associated with greater copeptin concentrations in men with type 1 diabetes: A brief report from the T1D exchange Biobank.Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats.
P2860
Q28085593-0F089A66-97BD-456A-AFBB-76754C432834Q34056947-310ED63B-232B-42EC-9866-203E247FBD94Q35563596-B4BE2F9E-C2B5-416E-A561-F5A6E381C7F1Q35621908-03B3FDE0-1537-425D-B9AA-FD32A005BD5DQ36099419-3D92856F-6536-42E0-9330-D5CDC7B3EB78Q36965316-17E5C470-0419-4273-BE1D-A5B32D4F7668Q37147707-875A0E02-ED26-4842-9D0D-C6378EC69C74Q37193463-073A8E9E-64BC-458D-8781-C59D7DC83694Q37257539-C1EB6A45-BA6E-41E1-98FA-4685D83DB6BAQ37278044-33756B21-D245-4760-BFCD-B1A572C4480EQ38709338-DAE3A72B-B15B-45F2-A823-2A0180319B34Q39422254-80B55106-0325-425B-B732-16A3A4E8CA80Q41997691-146E3AF9-9C0C-4AD6-A76A-E0D41849B596Q42034139-4F4E4E14-860F-4DD5-B518-09B4C43A8837Q45005733-FB8409A9-524A-42ED-9088-A0C26B4AF94FQ45233930-E94F7470-5E9E-4507-AB92-37506D66C729Q46371934-DB36885D-C1B1-4144-8BE9-3F95DB1D6D92Q48132369-327C0D3E-B8F9-4EF4-9C40-289D9714E84DQ48938162-1A582A0A-7A60-4DA0-87C8-5FB067244CCBQ49049804-34FC2807-622A-474C-AFB2-CE344D2CC6E7Q50300651-9AA6D7EF-0E45-4388-9A4C-F19D043F6914Q51308854-DE09C5CE-E682-4764-AFD5-67AB6FD7AB4C
P2860
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Plasma vasopressin in uncontrolled diabetes mellitus.
@en
Plasma vasopressin in uncontrolled diabetes mellitus.
@nl
type
label
Plasma vasopressin in uncontrolled diabetes mellitus.
@en
Plasma vasopressin in uncontrolled diabetes mellitus.
@nl
prefLabel
Plasma vasopressin in uncontrolled diabetes mellitus.
@en
Plasma vasopressin in uncontrolled diabetes mellitus.
@nl
P2093
P356
P1433
P1476
Plasma vasopressin in uncontrolled diabetes mellitus.
@en
P2093
P304
P356
10.2337/DIAB.28.5.503
P407
P577
1979-05-01T00:00:00Z